Chronic obstructive pulmonary disease (COPD) kills approximately 2.8 million people each year, and more than 80% of COPD cases can be attributed to smoking. Leukocytes recruited to the lung contribute to COPD pathology by releasing reactive oxygen metabolites and proteolytic enzymes. In this work, we investigated where leukocytes enter the lung in the early stages of COPD in order to better understand their effect as a contributor to the development of COPD. We simultaneously evaluated the parenchyma and airways for neutrophil accumulation, as well as increases in the adhesion molecules and chemokines that cause leukocyte recruitment in the early stages of tobacco smoke induced lung disease. We found neutrophil accumulation and increased expression of adhesion molecules and chemokines in the bronchial blood vessels that correlated with the accumulation of leukocytes recovered from the lung. The expression of adhesion molecules and chemokines in other vascular beds did not correlate with leukocytes recovered in bronchoalveolar lavage fluid (BALF). These data strongly suggest leukocytes are recruited in large measure through the bronchial circulation in response to tobacco smoke. Our findings have important implications for understanding the etiology of COPD and suggest that pharmaceuticals designed to reduce leukocyte recruitment through the bronchial circulation may be a potential therapy to treat COPD.
References
[1]
Snider GL (1996) Epidemiology and natural history of COPD. In: Leff AR, editor. Pulmonary and critical care pharmacology and therapeutics. New York: McGraw-Hill. pp. 821–828.
[2]
Samet JM (2004) Adverse effects of smoke exposure on the upper airway. Tob Control 13: Suppl 1i57–i60.
[3]
Jeffery PK (2000) Comparison of the structural and inflammatory features of COPD and asthma. Giles F Filley Lecture Chest 117: 251S–260S.
[4]
Barnes PJ (2000) Chronic obstructive pulmonary disease. N Engl J Med 343: 269–280.
[5]
Barnes PJ, Shapiro SD, Pauwels RA (2003) Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 22: 672–688.
[6]
Malik AB, Lo SK (1996) Vascular endothelial adhesion molecules and tissue inflammation. Pharmacol Rev 48: 213–229.
[7]
Di Stefano A, Maestrelli P, Roggeri A, Turato G, Calabro S, et al. (1994) Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am J Respir Crit Care Med 149:
[8]
Capelli A, Di SA, Gnemmi I, Balbo P, Cerutti CG, et al. (1999) Increased MCP-1 and MIP-1beta in bronchoalveolar lavage fluid of chronic bronchitics. Eur Respir J 14: 160–165.
[9]
Turato G, Di SA, Maestrelli P, Mapp CE, Ruggieri MP, et al. (1995) Effect of smoking cessation on airway inflammation in chronic bronchitis. Am J Respir Crit Care Med 152: 1262–1267.
[10]
de Boer WI, Sont JK, van SA, Stolk J, van Krieken JH, et al. (2000) Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J Pathol 190: 619–626. 10.1002/(SICI)1096-9896(200004)190:5<619？::AID-PATH555>3.0.CO;2–6[pii];10.1002/(SICI)1096-9896(200004)190？:5<619::AID-PATH555>3.0.CO;2–6[doi].
[11]
Davis BB, Liu JY, Tancredi DJ, Wang L, Simon SI, et al. (2011) The anti-inflammatory effects of soluble epoxide hydrolase inhibitors are independent of leukocyte recruitment. Biochem Biophys Res Commun 410: 494–500. S0006-291X(11)00966-1 [pii];10.1016/j.bbrc.2011.06.008 [doi].
[12]
Teague SV, Pinkerton KE, Goldsmith M, Gebremichael A, Chang S, et al. (1994) Sidestream Cigarette-Smoke Generation and Exposure System for Environmental Tobacco-Smoke Studies. Inhalation Toxicology 6: 79–93.
[13]
Manly BFJ (2007) Randomization, Bootstrap, and Monte Carlo Methods in Biology. London: Chapman & Hall.
[14]
Conover WJ, Iman RL (1982) Analysis of covariance using the rank transformation. Biometrics 38: 715–724.
[15]
Good PI (2004) Efficiency comparisons of rank and permutation tests by Statistics in Medicine 2001; 20:705–731. Stat Med 23: 857. 10.1002/sim.1738 [doi].
[16]
Doerschuk CM, Beyers N, Coxson HO, Wiggs B, Hogg JC (1993) Comparison of neutrophil and capillary diameters and their relation to neutrophil sequestration in the lung. J Appl Physiol 74: 3040–3045.
[17]
Doerschuk CM, Winn RK, Coxson HO, Harlan JM (1990) CD18-dependent and -independent mechanisms of neutrophil emigration in the pulmonary and systemic microcirculation of rabbits. J Immunol 144: 2327–2333.
[18]
Downey GP, Worthen GS, Henson PM, Hyde DM (1993) Neutrophil sequestration and migration in localized pulmonary inflammation. Capillary localization and migration across the interalveolar septum. Am Rev Respir Dis 147: 168–176.
[19]
Lien DC, Wagner WW Jr, Capen RL, Haslett C, Hanson WL, et al. (1987) Physiological neutrophil sequestration in the lung: visual evidence for localization in capillaries. J Appl Physiol 62: 1236–1243.
[20]
Doerschuk CM (2001) Mechanisms of leukocyte sequestration in inflamed lungs. Microcirculation 8: 71–88.
[21]
Folkesson HG, Matthay MA (1997) Inhibition of CD18 or CD11b attenuates acute lung injury after acid instillation in rabbits. J Appl Physiol 82: 1743–1750.
[22]
Folkesson HG, Matthay MA, Hebert CA, Broaddus VC (1995) Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest 96: 107–116. 10.1172/JCI118009 [doi].
[23]
Goldman G, Welbourn R, Kobzik L, Valeri CR, Shepro D, et al. (1995) Neutrophil adhesion receptor CD18 mediates remote but not localized acid aspiration injury. Surgery 117: 83–89.
[24]
Ramamoorthy C, Sasaki SS, Su DL, Sharar SR, Harlan JM, et al. (1997) CD18 adhesion blockade decreases bacterial clearance and neutrophil recruitment after intrapulmonary E. coli, but not after S. aureus. J Leukoc Biol 61: 167–172.
[25]
Wagner JG, Roth RA (2000) Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev 52: 349–374.
[26]
Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454: 428–435.
[27]
Yu B, Kodavanti UP, Takeuchi M, Witschi H, Pinkerton KE (2008) Acute tobacco smoke-induced airways inflammation in spontaneously hypertensive rats. Inhal Toxicol 20: 623–633. 792913012 [pii];10.1080/08958370701861538 [doi].
[28]
Shen Yi-Hsin (2008) Spontaneously Hypertensive Rats as an Animal Model for Tobacco Smoke-Induced Chronic Obstructive Pulmonary Disease [dissertation].
[29]
Zhong CY, Zhou YM, Pinkerton KE (2008) NF-kappaB inhibition is involved in tobacco smoke-induced apoptosis in the lungs of rats. Toxicol Appl Pharmacol 230: 150–158.
[30]
Di SA, Caramori G, Oates T, Capelli A, Lusuardi M, et al. (2002) Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur Respir J 20: 556–563.
